News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Erman Akkus: Our study on SGLT2 and papillary RCC
Erman Akkus/X
Feb 10, 2025, 15:21

Erman Akkus: Our study on SGLT2 and papillary RCC

Erman Akkus, Medical Oncology Fellow at Ankara University, shared an article on X:

“Our study on SGLT2 and papillary RCC has been published!

SGLT2 inhibitors dramatically changed the treatment of diabetes, heart failure and chronic kidney disease.

SGLT2 is selectively expressed in kidney.

Our study suggest SGLT2 may be a potential biomarker and target in papillary RCC, calling for further studies.”

Erman Akkus: Our study on SGLT2 and papillary RCC

Sodium-Glucose Cotransporter 2 (SGLT2) as a Potential Biomarker and Target in Papillary Renal Cell Carcinoma.

Authors: Erman Akkus, et al.

 Erman Akkus: Our study on SGLT2 and papillary RCC

Ankara University cancer Erman Akkus fight against cancer Global fight against cancer Kidney Disease MedOnc OncoDaily Oncology RCC renal cell carcinoma SGLT2 Sodium-Glucose Cotransporter
Special Coverage
Science
Feb 10, 2025, 15:21
Erman Akkus: Our study on SGLT2 and papillary RCC
Blog
Feb 10, 2025, 15:11
Jame Abraham: Congratulating George Budd for receiving the Legacy Coin
Blog
Feb 10, 2025, 15:03
Theresa Petee: Living Beyond Breast Cancer is hiring a Coordinator of Healthcare Provider Outreach
Blog
Feb 10, 2025, 14:47
Wafaa M Rashed: Cutting Research is Cutting Hope
Oncolibrary
Feb 10, 2025, 14:26
Mesothelioma Guideline Updates from ASCO 2024: Key Advances in Diagnosis and Treatment
Science
Feb 10, 2025, 14:12
Myeloma Paper of the Day, February 10th, suggested by Robert Orlowski
Science
Feb 10, 2025, 11:22
Sorafenib- and anthracycline-based therapies for patients with desmoid tumors - ACS Journal Cancer
Blog
Feb 10, 2025, 11:18
Ashley Love Sumrall: Another great meeting at ASCO HQ
Insight
Feb 10, 2025, 11:12
Raymond Chan: The development of the South Australian approach to cancer navigation
Insight
Feb 10, 2025, 11:05
ACS diet and physical activity guidelines for cancer prevention - CA: A Cancer Journal for Clinicians
Blog
Feb 10, 2025, 10:58
Sir Chris Hoy has launched Tour de 4 to challenge perceptions of stage 4 cancer - UICC
Insight
Feb 10, 2025, 10:52
Tanja Obradovic: How current FDA policy can affect advances in AI